Valneva SE VALN
NASDAQ VALN
$6.91 -0.15 (-2.10%)
As of: Sep 4, 2026 · 2:29 PM EDT

Valneva SE (VALN) Gross Profit (2021 - 2026)

Valneva SE (VALN) posted Gross Profit of $5.5 million for Q1 2026, up 95.6% sequentially from $2.8 million in Q4 2025, and down 79.92% YoY from $27.5 million in Q1 2025.

Analysis

Valneva SE (VALN) Gross Profit (2021 - 2026) Analysis & Trends

Valneva SE has reported Gross Profit for 6 years, with the latest figure at $5.5 million in Q1 2026.

  • Quarterly Gross Profit fell 79.92% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.3 million (down 61.24% YoY) and the FY2025 annual result came in at $59.1 million, down 15.7% from the prior year.
  • Gross Profit advanced to $5.5 million in Q1 2026 per VALN's latest filing, from $2.8 million in the prior quarter.
  • Over five years, Gross Profit peaked at $126.5 million in Q3 2022 and troughed at -$92.0 million in Q2 2022.
  • A 5-year average of $13.0 million and a median of $14.0 million in 2023 frame the typical range for Gross Profit.
  • The sharpest annual moves came in 2022 and 2023: Gross Profit plunged 1937.35% in 2022, then jumped 261.9% in 2023.
  • Over 5 years, Gross Profit stood at -$10.5 million in 2022, then surged by 261.9% to $17.0 million in 2023, then jumped by 47.83% to $25.2 million in 2024, then tumbled by 88.77% to $2.8 million in 2025, then surged by 95.6% to $5.5 million in 2026.
  • According to Business Quant data, Gross Profit over the past three periods registered $5.5 million, $2.8 million, and -$2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Valneva SE 588.63 Mn 447.37 Mn 1.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.86 Mn
Mar 31, 2026 5.53 Mn
Dec 31, 2025 13.52 Mn
Sep 30, 2025 6.43 Mn
Jun 30, 2025 27.41 Mn
Mar 31, 2025 27.55 Mn
Dec 31, 2024 27.47 Mn
Sep 30, 2024 22.12 Mn
Jun 30, 2024 15.71 Mn
Mar 31, 2024 11.51 Mn
Dec 31, 2023 17.04 Mn
Sep 30, 2023 18.61 Mn
Jun 30, 2023 7.49 Mn
Mar 31, 2023 13.98 Mn
Dec 31, 2022 -10.52 Mn
Sep 30, 2022 126.47 Mn
Jun 30, 2022 -92.03 Mn
Mar 31, 2022 8.96 Mn
Dec 31, 2021 285.88 Mn
Sep 30, 2021 -120.83 Mn